Diabetic retinopathy (DR), the most common microvascular compilation of diabetes, is the leading cause of vision loss and blindness worldwide. Recent studies indicate that retinal neuron impairment occurs before any noticeable vascular changes in DR, and retinal ganglion cell (RGC) degeneration is one of the earliest signs. Axons of RGCs have little capacity to regenerate after injury, clinically leading the visual functional defects to become irreversible. In the past two decades, tremendous progress has been achieved to enable RGC axon regeneration in animal models of optic nerve injury, which holds promise for neural repair and visual restoration in DR. This review summarizes these advances and discusses the potential and challenges for developing optic nerve regeneration strategies treating DR.
Stem cell-derived secreted factors could protect neurons in neurodegenerative disease or after injury. The exact neuroprotective components in the secretome remain challenging to discover. Here we developed a cell-to-cell interaction model to identify a retinal ganglion cell (RGC)-protective factor derived from induced pluripotent stem cells (iPSCs). Primary RGCs were co-cultured with iPSCs or treated with iPSC-conditioned media in vitro. Cell viability were assayed using live-cell staining, and culture supernatant were analyzed via multiplexed antibody-based assays and ELISA. In vivo tests were carried out under mouse optic nerve crush model and RGC transplantation study in rats. Paired t-tests were used for data analysis between two groups. RGC viability was significantly enhanced when iPSCs were first stimulated with RGC-derived supernatant before iPSC-conditioned medium was collected and added into RGC culture. A significant increase of stem cell growth factor-beta (SCGF-β) concentration was detected in the latter conditioned medium. SCGF-β enhanced RGC survival in vitro and in vivo, and RGC-derived interleukin-12(p70) (IL-12[p70]) promotes secretion of iPSC-derived SCGF-β. Downstream of this IL-12(p70)-to-SCGF-β axis, ngn2 was significantly upregulated, and was found both necessary and sufficient for RGC survival. This study addresses a longstanding question of how neurons and stem cells interact to promote neuroprotection, and define a novel molecular interaction pathway whereby RGC’s secretion of IL-12(p70) enhances iPSCs’ secretion of SCGF-β, and SCGF-β protects RGCs via upregulating ngn2, suggesting that neurons may call on stem cells for their own protection.
18 December 2025 in American Journal of Case Reports
BACKGROUND Infantile corneal foreign bodies (CFBs) are rare and frequently result in delayed diagnoses and treatment challenges. This report describes a case of a very young infant with a small plastic CFB that was successfully removed. CASE REPORT A 2-month-old boy was observed to have a "small dot" foreign body on his left cornea by his parents. No crying response to the CFB or other symptoms had ever been identified. Slit lamp examination revealed the presence of a small, oval, plastic foreign body in the corneal epithelial layer. This CFB was determined to be an ornament affixed to the dress that the babysitter was wearing at the time. For CFB removal, medical sedation was rejected by the infant's guardian. The initial attempt to flush the CFB out with saline or extract the CFB using a cotton-tipped applicator alone proved unsuccessful. Subsequent release of the CFB from the cornea was facilitated by the addition of proparacaine hydrochloride drops to the conjunctival sac and the use of a 1-mL needle, which was then adhered to the cotton-tipped applicator, thereby enabling its removal. CONCLUSIONS CFBs in young infants may not manifest any symptoms and thus can be easily ignored. The removal of plastic CFBs in those young infants who exhibit limited communication and cooperation abilities remains a challenging procedure. This report proposes a viable and low-risk, office-based approach to address the issue of CFB removal in infants.